AMIX · Autonomix Medical Inc. Common Stock
View on chartInsiders & Stakes
| Hauser Bradley CEO and President | ▲ Buy | Grant | 27,000 Shares held | 9/3/2026 | View profile |
| KLEMP WALTER V Director | ▲ Buy | Grant | 20,118 Shares held | 9/3/2026 | View profile |
| Smith Trent N. CFO | ▲ Buy | Grant | 15,119 Shares held | 9/3/2026 | View profile |
| Bisson Lori Director | ▲ Buy | Grant | 13,119 Shares held | 9/3/2026 | View profile |
Transaction History
| Smith Trent N. | ▲ Buy | Grant | 15,000 | — | 9/3/2026 |
| KLEMP WALTER V | ▲ Buy | Grant | 13,000 | — | 9/3/2026 |
| Bisson Lori | ▲ Buy | Grant | 13,000 | — | 9/3/2026 |
| Hauser Bradley | ▲ Buy | Grant | 27,000 | — | 9/3/2026 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
Autonomix Gets Positive FDA Feedback, Completes Pre-Submission Meeting
The company reported that the FDA gave positive feedback that supports a 510(k) clearance pathway for its product. It also completed a pre‑submission meeting with the agency regarding its transvascular sensing platform. These steps move the regulatory process forward and may affect the company's future prospects. The stock is currently near its $7.83 support level.
Autonomix Gets Positive FDA Feedback, Completes Pre-Submission Meeting. The company reported that the FDA gave positive feedback that supports a 510(k) clearance pathway for its product. It also completed a pre‑submission meeting with the agency regarding its transvascular sensing platform. These steps move the regulatory process forward and may affect the company's future prospects. The stock is currently near its $7.83 support level.